Imperial College London

Dr Charlotte-Eve Short

Faculty of MedicineDepartment of Infectious Disease

Academic Clinical Lecturer
 
 
 
//

Contact

 

+44 (0)7817 632 636c.short CV

 
 
//

Location

 

455Norfolk PlaceSt Mary's Campus

//

Summary

 

Summary

Following completion of my Wellcome Trust Clinical PhD programme at Imperial College London, I was awarded my PhD, entitled ‘The immunological basis of preterm birth in HIV-1 infected pregnant women’ in January 2020.

I was appointed to my current position as an Academic Clinical Lecturer in February 2020 to continue my doctoral research theme in the Section of Virology, Dept of Infectious Disease as part of the March of Dimes European Preterm Birth Research Centre at Imperial College.

My focus areas are the study of the vaginal microbiota and immunogenic pathways in the female genital tract underlying the excess risk of preterm birth in pregnant women living with HIV-infection. My wider interests lie in the immuno-pathogenesis of genital tract infections and HIV co-infection complementing my clinical specialist training in Genitourinary and HIV Medicine.

Publications

Journals

Rosa A, Pye VE, Graham C, et al., 2021, SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity, Science Advances, Vol:7, ISSN:2375-2548

Pereira C, Harris B, Di Giovannantonio M, et al., 2021, Antibody response to SARS-CoV-2 infection is not associated with Post-COVID-19 Syndrome in healthcare workers, Journal of Infectious Diseases, Vol:223, ISSN:0022-1899, Pages:1671-1676

Thwaites RS, Sanchez Sevilla Uruchurtu A, Siggins MK, et al., 2021, Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19, Science Immunology, Vol:6, ISSN:2470-9468, Pages:1-17

Short C-E, Brown R, Quinlan R, et al., 2021, Lactobacillus-depleted vaginal microbiota in pregnant women living with HIV-1 infection are associated with increased local inflammation and preterm birth, Frontiers in Cellular and Infection Microbiology, Vol:10, ISSN:2235-2988

Rosa A, Pye VE, Graham C, et al., 2021, SARS-CoV-2 recruits a haem metabolite to evade antibody immunity., Medrxiv

More Publications